leadf
logo-loader
viewCreso Pharma Ltd

Creso Pharma's Canadian subsidiary Mernova receives third purchase order from NSLC

The order is the third from NSLC in the last four weeks, with the two previous orders for its premium strains, continuing to sell well.

Creso Pharma Ltd - Creso Pharma's Canadian subsidiary Mernova receives third purchase order from NSLC
Mernova’s Ritual Green Mimosa product is now sold through NSLC stores and e-commerce platform

Creso Pharma Limited’s (ASX:CPH) (OTCMKTS:COPHF) (FRA:1X8) wholly-owned Canadian subsidiary, Mernova Medicinal Inc, a licensed producer in Nova Scotia, has received and delivered its third purchase order from the Nova Scotia Liquor Corporation (NSLC).

The third purchase order is for 20 cases of Mernova’s ‘Mimosa’ (15-20% THC, less than 1% CBD) strain, which is Mernova’s value brand now launched under the Ritual Green brand.

Introduction of the strain will allow Mernova to pursue a much larger addressable market, targeting consumers who are seeking premium quality at a more reasonable price point. 

Further orders to be finalised

Mernova managing director Jack Yu said: “Securing this additional purchase order from the NSLC is a significant achievement, and further validates the success of the recent Ritual Green product launch.

“Our products continue to garner very positive feedback from customers and we are confident that the Mimosa strain will unlock a large portion of the market that we can capitalise on in the near term.

“We look forward to updating shareholders on progress in Nova Scotia, additional strain launches under the Ritual Green product range, and further orders to be finalised in the near term.”

Confirms success of Ritual Green brand

The order is the third from NSLC in the last four weeks, with the two previous orders for its premium strains, HPG13 (20-25% THC, less than 1% CBD), and Lemon Haze (20-25% THC, less than 1% CBD) continuing to sell well.

Creso is very confident that it will continue to receive purchase orders from NSLC for its Mimosa and premium quality strains.

This will allow the company to build on the around C$320,000 in revenue it has generated in the last month from the NSLC.

Mernova’s Ritual Green products are sold through NSLC stores and e-commerce platform.

The additional purchase order serves as further confirmation of the success of the Ritual Green brand of high-quality cannabis products in the rapidly growing Canadian retail recreational market.

Mernova continues to make significant inroads into the Nova Scotia recreational market, with its diverse products offering premium quality at a competitive price point.

Quick facts: Creso Pharma Ltd

Price: 0.035 AUD

ASX:CPH
Market: ASX
Market Cap: $24.09 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Creso Pharma Ltd named herein, including the promotion by the Company of Creso Pharma Ltd in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Creso Pharma subsidiary Mernova granted sales license from Health Canada

Creso Pharma (ASX:CPH) subsidiary Mernova managing director Jack Yu and vice president Isaac Allen joined Steve Darling from Proactive to discuss the granting of their sales license from Health Canada and what it allows them to do. Isaac Allen tells Proactive they are gearing up sales...

on 12/6/20

2 min read